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Mutations in the NOD2 (CARD15) gene predispose to Crohn's disease (CD), a human chronic inflammatory bowel disorder, and can cause
Blau syndrome. During an investigation of an apparent correlation between a frameshifting mutation in the canonical first exon of NOD2 of
marmoset and tamarin species and their susceptibility to chronic colitis, we found that, contrary to previous reports, the basal levels of NOD2
transcripts in tissues relevant to CD arise from a distinct novel promoter and first exon. The canonical first exon, by contrast, seems to be of
negligible transcriptional importance under physiological conditions, and its reading frame has been disrupted twice during primate evolution.
Thus the main NOD2/CARD15 protein isoform produced in humans and other primates is 27 amino acids shorter than previously reported, starting
at a conserved methionine in exon 2. We show that there is no significant association between variants in the novel NOD2 promoter region and CD.
© 2007 Elsevier Inc. All rights reserved.Keywords: Crohn's disease; NOD2; CARD15; Blau syndrome; Promoter regions; Colitis; Callitrichinae; MarmosetCrohn’s disease (CD) is a form of inflammatory bowel
disease characterized by chronic relapsing ulceration and
inflammation of the gastrointestinal tract [1]. Genetic studies
identified the NOD2 gene (also called CARD15) as a
susceptibility gene for CD [2–4]. Three commonly observed
variants in NOD2 (R702W, G908R, and L1007fs) are
associated with CD, although multiple rarer variants have
been identified, some of which are also likely to predispose to
CD [5–7]. Heterozygotes for these mutations have a 2- to 3-fold
increase in risk of CD, with a 17-fold increase in homozygotes
or compound heterozygotes [8]. NOD2 activates NF-κB in
response to the peptidoglycan component of bacterial cell walls
via its ligand muramyl dipeptide, and NOD2 mutations result in☆ Sequence data from this article have been deposited the EMBL/GenBank
Data Libraries under Accession Nos. DQ868963–DQ868975.
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doi:10.1016/j.ygeno.2007.07.009a reduction of this response [9,10]. Thus a constitutional
deficiency in the innate immune response appears to contribute
to the pathogenesis of CD. NOD2 is also mutated in the rare
autosomal dominant disorder Blau syndrome, but the mutational
spectrum is different from that of CD and is associatedwith a gain
rather than a loss of function [11]. The NOD2 gene, which is
located on chromosome 16q21, has 12 exons and encodes a
protein of 1040 amino acids [12]. The protein contains two
N-terminal caspase recruitment domains (CARDs), a central
nucleotide-binding oligomerization domain (NOD), andmultiple
C-terminal leucine-rich repeats. An isoform of NOD2 (NOD2-S)
that is generated by skipping of exon 3 and is truncated in the
second CARD can down-regulate the activation of NF-κB by
NOD2 [13]. Multiple splice variants of NOD2 have been
reported, the functional significance of which is unknown [14].
In our previous study of the evolution of NOD2 we found
that the open reading frame (ORF) of humans and apes appears
to start in the first exon [6], contributing an additional N-
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vertebrates. We also showed that the New World monkey Sa-
guinus oedipus, which is known to be highly susceptible to
chronic colitis [15], has a frameshifting mutation in the
canonical exon 1 of NOD2. This was of considerable interest,
since it raised the possibility that a lack of expression of NOD2
might contribute to susceptibility to colitis in this species. The
initial characterization of NOD2/CARD15 [12] revealed two
potential in-frame translation initiation sites at Met1 and Met28,
both of which were used, although Met1 appeared to be more
efficient in an in vitro translation assay [12]. The presence of
these alternative initiation sites, combined with the nonorthol-
ogy of the first exon of NOD2 in the three independently
deposited NOD2 cDNA sequences (human, mouse, and cow),
has led us to explore the biological significance of the proposed
first exon of the human gene. We show here that a novel
alternative promoter and novel first exon of NOD2 are
responsible for the abundant constitutive transcript isoforms
in human tissues and that primate NOD2, like other vertebrate
NOD2’s, is likely to be translated from the first methionine
codon in exon 2 (known as Met28) to produce a protein of 1023
rather than 1040 amino acids. We have also evaluated the novel
promoter and first exon for sequence variants that might
predispose to Crohn's disease.
Results
Canonical exon 1 ORF has been disrupted twice during
primate evolution
While acquiring sequences of NOD2 exons from various
primate species, we noted that the New World monkey S.
oedipus (cotton-top tamarin; Accession No. AY594138), but
not human, chimpanzee, or gibbon (Accession Nos. AF178930,
AY594162, and AY594150), had a frameshifting insertion of a
single G nucleotide in canonical exon 1 [6] (hereafter referred to
as CanE1), meaning that, as in nonprimates such as mice and
cattle, translation would have to commence in exon 2. Recalling
that S. oedipus (in captivity, but not in the wild) is known to
have a species-wide predisposition to a chronic colitis that has
been likened to Crohn's disease [15–17], it occurred to us that
this insertion might be a candidate predisposing mutation. We
therefore used genomic PCR and direct sequencing to acquire
CanE1 sequences from a range of other callitrichid monkeys
(the emperor tamarin S. imperator, the red-bellied tamarin S.
labiatus, the saddle-back tamarin S. fuscicollis, Goeldi’s
monkey Callimico goeldii, the common marmoset Callithrix
jacchus, and the golden-headed lion tamarin Leontopithecus
chrysomelas; Accession Nos. DQ868965–DQ868971), as well
as a cebid New World monkey (owl monkey Aotus trivirgatus;
Accession No. DQ868972). These sequences showed that all
callitrichids had the same insertional mutation (Fig. 1) but that
the non-callitrichid A. trivirgatus had an intact open reading
frame, suggesting that this apparent frameshift was a calli-
trichid-specific variant [18].
We studied the literature for evidence of bowel disorders in
callitrichids other than S. oedipus and duly found numerouspeer-reviewed and anecdotal reports of high incidence of
chronic colitis in S. mystax, S. labiatus, S. fuscicollis, S.
oedipus, Ca. jacchus (often labeled as “wasting marmoset
syndrome”), but not in non-callitrichid New World monkeys
[19–25] (unlike S. oedipus, colitis in other callitrichids is not
associated with a high incidence of colon cancer). This
apparently perfect correlation between a disrupted NOD2
open reading frame and a high prevalence of chronic colitis in
captivity was clearly tantalizing, and led us to test the effects of
such a mutation on the translation of the NOD2 transcript;
Ogura et al. have previously shown that methionines in both
CanE1 (Met1) and exon 2 (Met28) may be used for translation
initiation (their Fig. 3D) [12], so the likely translational
consequences were unclear.
We therefore generated a series of constructs in the
mammalian expression vector pGW1, fusing various versions
of NOD2 CanE1 with NOD2 exon 2 and sequence encoding a
readily detectable C-terminal hemagglutinin (HA) tag (see
Supplementary Fig. 1A). These constructs included normal
sequences from Homo sapiens, S. oedipus, and A. trivirgatus,
together with versions of the human sequence with either Met1
or Met28 mutated to a valine (“M1V” and “M28V,”
respectively). These constructs were transfected transiently
into COS-7 cells and the protein products were separated by
high-resolution SDS–PAGE and detected by Western blotting
with anti-HA antibody. In contrast to Ogura et al. [12], only
products initiating from Met1 were seen, and these were
generated only from those constructs bearing an intact upstream
open reading frame (normal and M28V H. sapiens and normal
A. trivirgatus sequences) and not from M1V H. sapiens or
normal S. oedipus sequence (see Supplementary Fig. 1B). This
suggests that Met28 cannot function as an efficient initiation
codon in this context and that the callitrichid-specific insertion
appears to be a translationally null mutation.
At this point we chanced to sequence NOD2 CanE1 from the
COS-7 cells that we had been using as a transfection host
(Accession No. DQ868964). COS-7 cells are derived from
Cercopithecus aethiops (African green monkey), which, like the
great apes, is from the catarrhine branch of the primates.
Surprisingly, this animal, which does not to our knowledge have
a high incidence of colitis, was also found to have a
frameshifting insertional mutation in CanE1, this time of two
G nucleotides, at the same position as that found in the
callitrichids (Fig. 1). The same dinucleotide insertion was found
in the public sequence for Macaca mulatta (rhesus macaque),
another Old World monkey. This result suggested that perhaps
the primate-specific upstream open reading frame was not
subject to purifying selection and was essentially free to vary.
Indeed, the pairwise Ka/Ks values between CanE1 sequences of
those primates that have an intact ORF are greatly in excess of
unity (data not shown), suggesting absence of purifying
selection, though the small size of exon 1 makes this result
weak. Furthermore, the recently released genome sequence of
the gray mouse lemur Microcebus murinus (a strepsirrhine)
shows that the CanE1 sequence of this animal does not have an
intact donor splice site (see Fig. 1A). In combination with our
finding that Met28 could not drive efficient translation, at least
Fig. 1. NOD2 canonical exon 1 (CanE1) ORF is not maintained in primates. (A) Alignment of the 3′ half of CanE1 from a range of primates. Box indicates alleged
exon. Arrow indicates reported [12] translation initiation codon (shaded). Bold letters indicate insertion mutations in callitrichids and Old World monkeys. Accession
Nos. DQ868963–DQ868972. (B) Maximum parsimony (DNAPars) phylogenetic tree (left-hand side) generated from full sequence of NOD2 CanE1, rooted usingMi.
murinus CanE1 as an outgroup and presented adjacent to the translations of the corresponding transcripts (right-hand side). The tree confirms the monophyly of the
callitrichid sequences and reveals the most parsimonious points at which insertion mutations may have occurred (asterisks). Bold lines, bold species names, and
underlined peptide sequence—putative intact ORF. Italics—shifted open reading frames. Vertical arrow—position of insertion mutations.
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the evidence that CanE1 actually is the first exon of primate
NOD2 genes.
Identification of a candidate alternative human NOD2 exon 1
The identification of the human NOD2 CanE1 (as presented
in GenBank cDNA entries NM_022162, AY187243,
AY187246, and AF178930) originates in a paper by Ogura et
al., in which 5′RACE was performed on RNA from a tissue
pathogenetically less relevant to CD (mammary gland) [12].
Although subsequent workers have successfully performed RT-
PCR between CanE1 and other exons [13,14,26], to our
knowledge the use of this CanE1 has not been independently
assessed. We decided to use bioinformatic methods to address
its relationship to genomic and expressed sequences in other
species.
The mouse Nod2 exon 1 appears to be controversial—one
cDNA sequence (AF520774) has a first exon that consists
almost entirely of a MaLR LTR repeat, while the other
(AY160221) has a unique GC-rich first exon. The former is
not represented at all in the EST database, while the latter is
present in 35 murine ESTs. We therefore assume that the
sequence represented by AY160221 contains the major mouseNod2 exon 1. The only other independently acquired mamma-
lian Nod2 cDNA sequence (i.e., not merely predicted from the
human) was bovine NOD2, AY518737.
Of particular concern was the fact that the alleged first exons
of mouse, human, and bovine NOD2 do not resemble each
other. Their nonorthology is proven by the presence upstream of
the human NOD2 exon 2 of separate orthologues of the murine
and bovine first exons (such that the alleged first exons are in
the order murine–human–bovine; the orthologue of the
canonical human first exon is also apparent in the mouse
Nod2 gene). As the interspecific similarity of these sequences is
very low (small islands of similarity, each of marginal statistical
significance, but colinearly arranged), the sequence comparison
was aided by dot-plotting, which essentially adduces syntenic
information to make orthology more apparent. While the
sequence of the first exons of genes can often vary significantly
between mammalian species, it is rare for them to be
nonorthologous.
Naturally it is formally possible that the mammalian NOD2
gene has multiple promoters, with different promoters being
identified by chance in each of the three species. However, the
absence of an orthologue of the bovine exon 1 in mouse, and its
lack of a donor splice site in human, led us to assess the
candidacy of the mouse exon 1 as a mammal-wide NOD2 exon
496 K. King et al. / Genomics 90 (2007) 493–5011; moreover, it is the only NOD2 first exon represented in the
EST database. Strikingly, we found orthologues of mouse exon
1 in all mammalian genome sequences examined, and although
there was substantial sequence variation within the exon, in
each case the donor splice site and the surrounding 20–30 bp
were highly conserved (see Fig. 2). To our mind this made this
sequence, which we term “alternative exon 1” (hereafter,
AltE1), a likely first exon for mammalian NOD2 genes.
In addition to AltE1 sequences gleaned from the public
databases, we used genomic PCR to amplify orthologous
sequences from the Old World monkey Ce. aethiops and the
New World monkey S. oedipus (Accession Nos. DQ868974
and DQ868975); these are also presented in Fig. 2B.
AltE1 is the principal NOD2 exon 1 in primates
We set about assessing the use of AltE1 in two ways.
The first was to use 5′cRACE to survey sequences open-Fig. 2. Anatomy of NOD2 alternative promoter and exon 1 (AltE1). (A) Scheme, d
human NOD2 gene. Black boxes—exons. Vertical shading—20-mer repeat array. Bo
from various mammalian species. Vertical arrows above sequence show 5′ ends of 5′c
DQ868973, and oligo-cap clone DA224866), while vertical arrows below sequence s
box—AltE1. Small boxes—hexamer and octamer motifs described in text. Sequen
oedipus from this study (Accession Nos. DQ868974andDQ868975).endedly upstream of NOD2 exon 2 in endogenous human
transcripts. The second was to use semiquantitative RT-PCR
to compare its incorporation into NOD2 transcripts with that
of CanE1.
5′cRACE is a means of amplifying unknown sequences 5′
of known sequences in RNA molecules [27]. It is achieved via
a circular ssDNA intermediate, which allows true nesting of
the subsequent PCR with a concomitantly high yield and
specificity, even on low-abundance transcripts. We applied this
to human total white blood cell NOD2 transcripts, using
primers positioned in exon 2. A broad band of 5′cRACE
product was obtained; digestion with the rare-cutting restric-
tion enzyme BssHII, which cuts uniquely in AltE1, resulted in
a reduction in molecular weight of all visible products (data
not shown), indicating that the vast majority contain this exon.
The uncut product was ligated into vector pCR4, and 13
clones were sequenced; these represented five distinct but
related sequences, each containing the 3′-most 44–61 bp ofrawn to scale, of genomic region surrounding AltE1, CanE1, and exon 2 of the
ld horizontal lines—CpG island. (B) Alignment of ∼300bp surrounding AltE1
RACE products obtained in this study (large arrows indicate three longest clones,
how 5′ ends of mouse ESTs (large arrow indicates most prevalent 5′ end). Gray
ces acquired from Ensembl genomic sequences except for Ce. aethiops and S.
Fig. 3. NOD2 alternative promoter is the major promoter used in clinically
relevant tissues. Results of semiquantitative RT-PCR using primers in indicated
exons of the NOD2 gene (see left) are shown. Left-hand side shows a range of
human samples, as labeled, together with white blood cells (WBCs) from Ca.
jacchus.Right-hand side shows humanWBCs cultured with andwithout TNF-α.
Sizes of products are given at right.
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sequence corresponding to CanE1. The broad distribution of 5′
ends (arrows in Fig. 2) may represent a genuinely broad
spectrum of transcriptional start sites, as has been described for
CpG-rich promoters [28], or may reflect stochastic stalling of
reverse transcriptase while copying this highly GC-rich exon.
The sequence corresponding to the longest clone is presented
in Accession No. DQ868973. During the preparation of this
article we noted the new release of an EST sequence,
DA224866, this being the only human EST representing the
5′ end of the NOD2 transcript; this also uses AltE1. As it was
generated as part of a study of oligo-cap cDNA libraries [29]
and starts close to our 5′cRACE ends, this confirms that we
are likely to be identifying true transcriptional start sites rather
than reverse transcriptase stalling events.
The homogeneous results of this 5′cRACE experiment
suggest that AltE1 is the main constitutive first exon of NOD2
in white blood cells. An alternative explanation is that some
property of CanE1 strongly biases against its amplification in 5′
cRACE. However, while CanE1 (∼170 bp) is longer than AltE1
(∼60 bp), the latter is much more GC-rich (80% compared with
58%), a notorious challenge for both reverse transcriptase and
Taq DNA polymerase. On balance, we believe that the
preponderance of AltE1 over CanE1 (13 clones versus 0)
probably reflects the template population of mRNAs.
We then used semiquantitative RT-PCR to compare the
relative usage of the canonical and alternative NOD2
promoters in a range of human tissues relevant to CD
pathogenesis. For this, we used forward primers roughly
equal distances from the 3′ ends of the two first exons, together
with identical reverse primers in exon 4, giving similarly sized
products from the two transcripts (745 bp for that arising from
the AltE1 promoter and 757 bp for that arising from the CanE1
promoter). All primers were designed to work equally well on
human and New World monkey sequences. As controls we set
up RT-PCRs capable of amplifying all full-length NOD2
transcripts: one from exon 2 to exon 4 (using the same exon 4
reverse primers as above) and one from exon 4 to exon 12. We
controlled for RNA loading by amplifying transcripts from the
housekeeping gene glyceraldehyde-3-phosphate dehydrogen-
ase (GAPDH). RNA samples chosen were human white blood
cells, breast (the source of the original canonical NOD2
cDNA), colon, duodenum, SW480 (a cell line derived from a
human colon adenocarcinoma [30]), and white blood cells
from the common marmoset, Ca. jacchus. The RT-PCR results
show that the NOD2 gene (as detected by reactions spanning
exons 2–4 and 4–12) is transcribed at higher levels in human
and marmoset white bloods cells and in the SW480 cell line
and at lower levels in human breast, colon, and duodenum (see
Fig. 3). The promoter usage was striking; RT-PCR products
generated from transcripts originating from the alternative
promoter (AltE1) mirrored the generic NOD2 transcripts
almost exactly, while those originating from the canonical
promoter (CanE1) were barely amplified in SW480 and not at
all in the primary tissue samples (even breast; see Fig. 3).
We take the combined results of 5′cRACE and semiquanti-
tative RT-PCR to confirm that the alternative promoter is theoverwhelmingly major source of NOD2 transcripts in the
pathogenetically relevant human tissues and that use of the
canonical promoter is negligible. This tallies with the situation
in mouse, in which the orthologous AltE1-like exon is used in
all 35 pertinent ESTs.
As two previous studies [26,31] have shown substantial up-
regulation of CanE1 promoter-mediated transcription following
stimulation with TNF-α, we cultured human white blood cells
with and without TNF-α, extracted the RNA, and performed
semiquantitative RT-PCR as described above (Fig. 3, right).
This resulted in no appreciable change in expression from either
promoter.
The genomic context of AltE1
AltE1 lies ∼3.5 kb upstream of CanE1 and ∼6 kb
upstream of exon 2 of the NOD2 gene (see Fig. 2A). Like the
mouse first exon, it lies in the middle of a classic CpG island
(%GC=68.8%, obs/exp CpG=0.727, length 693 bp), some of
which is repetitive and therefore potentially variable (4 tandem
copies of the octamer TGCGGGGC in human and chimpanzee
and 2 in monkeys, 3 tandem copies of the hexamer AGCCGG
in human and 4 in chimpanzee and African green monkey—
the latter repeats lie within the exon itself). Like many CpG
islands, the region is rich in Sp1 binding sites. Unusually, the
sequence ∼300–1000 bp upstream of the human transcrip-
tional start site is a highly repetitive region (see Fig. 2A and
Supplementary Fig. 2), comprising approximately 32 copies
of an ∼20-bp GT-rich motif (GTGTGTGTGTTGGGAAGCG
or similar). This sequence is present in chimpanzee, in which
the array comprises only about 22 copies, and in the rhesus
monkey Ma. mulatta (about 20 copies). The existence in
GenBank of three independent genomic sequences of the
human alternative NOD2 promoter region (Accession Nos.:
long allele AJ303140, short allele AC007728 and
AC007608), between which this repeat array differs in length,
suggested to us that there is a substantial likelihood of length
polymorphism.
Table 1
Association test of NOD2 promoter repeat region haplotypes with CD
Haplotype Total
9–3–4 10–3–4 8–5–5 9–5–5 10–5–5
Controls 283 7 1 732 11 1034
Control frequency (%) 27.4 0.68 NA 70.8 1.06
Crohn's disease (CD) 303 7 0 738 18 1066
CD frequency (%) 28.4 0.66 NA 69.2 1.69
p value a 0.62 NA NA 0.46 0.3
a p value for difference in haplotype frequency between cases and controls.
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AltE1 is a novel exon of the NOD2 gene, which had not to
our knowledge been screened for variants or tested for
association with CD, a disease that is associated with variants
in other parts of this gene. We therefore set out to assess the
degree of sequence and length variation in the environs of the
true human promoter and first exon. The promoter repeat array
was PCR-amplified from the genomic DNA of 44 unrelated
individuals (CD and ulcerative colitis patients) and sequenced;
this revealed a G → A single base substitution (rs11645448 in
dbSNP) and three biallelic dinucleotide repeat length poly-
morphisms (see Supplementary Fig. 2). No variants were seen
in the exon itself, and none are listed in dbSNP. The first,
second, and third copies of the 32∼20-bp repeats were found to
have alleles comprising 9 or 10, 3 or 5, and 4 or 5 GT
dinucleotides, respectively. The observed haplotypes comprised
alleles 9–3–4 (n=13), 9–5–5 (n=74), and 10–5–5 (n=1); the
sequences of haplotypes 9–3–4 and 10–5–5 are shown in
Supplementary Fig. 2. The A allele of SNP rs11645448 was in
complete linkage disequilibrium with the 9–3–4 haplotype in
our sample of 88 chromosomes.
A case–control study of association with CD was performed
by using a length-based assay to genotype the polymorphic
repeat region in 533 CD patients and 517 controls. Two
additional aberrantly sized products were occasionally observed
during this study, and sequencing revealed novel rare
haplotypes with GT repeat lengths of 10–3–4 and 8–5–5.
None of the above three common haplotypes showed an
association with CD (χ2 test: p=0.58) or linkage disequilibrium
with any of the known NOD2 mutations (see Table 1).
Discussion
The principal finding described in this paper is the
identification of a novel promoter and first exon (AltE1) for
an important human disease gene, NOD2/CARD15. We make a
case that this is in fact the constitutive source of NOD2
transcripts in blood leukocytes and colon, as opposed to the
previously described canonical promoter and first exon (CanE1)
[12], as follows:
(a) The alleged primate-specific ORF in CanE1 has been
disrupted at least twice in primate evolution by
frameshifting mutations. Analysis of those ORFs that
are intact shows no evidence of the purifying selectionthat might be expected of a functional peptide-encoding
region. The CanE1 ORF therefore seems not to be a
significant biological entity.
(b) In our experiments, disruption of this ORF results in an
inability to translate from the second methionine codon
(Met28). This suggests that the presence of CanE1
inhibits translational initiation at Met28, perhaps because
of the presence of an additional conserved upstream out-
of-frame methionine codon, a factor previously shown to
be inhibitory to translational initiation [32].
(c) The human CanE1 has no clear orthologue in nonprimate
mammals. The mouse exon 1, which is present in all 35
relevant ESTs in GenBank, has orthologues in all
mammalian genomes examined. We call the human
orthologue of this sequence “alternative exon 1.”
(d) AltE1 lies in a strong CpG island and its donor splice site
is conserved in all mammalian sequences examined. It has
no methionine codons.
(e) AltE1 is the only sequence observed upstream of NOD2
exon 2 when 5′RACE is performed on human white
blood cell RNA. The 5′ end of the 5′RACE products lies
in a position similar to that of the 5′ ends of mouse Nod2
ESTs and the sole human oligo-cap EST.
(f) RT-PCR performed using primers spanning NOD2 AltE1
and exon 4 yields a similar expression profile across
pathologically relevant tissues (white blood cells, colon)
compared to that obtained from pan-NOD2 reactions
spanning exon 2 and exon 4 or exon 4 and exon 12.
Primers spanning CanE1 and exon 4 yielded no product
from these tissues.
We believe that together these findings make a strong case
for AltE1 being the constitutive first exon of the human NOD2
gene and, by extension, suggest that AltE1’s orthologues will be
the constitutive first exons of their respective genes. We found
NOD2 transcripts bearing CanE1 extremely hard to detect;
indeed they were seen only in a tumor cell line and even then at
levels at least an order of magnitude lower than AltE1. This
suggests that CanE1 is rarely used in normal human tissues, at
least in those considered important in the pathogenesis of CD
(white blood cells, colon). Of course it remains possible that
while AltE1 is the main promoter in normal tissues, CanE1 may
become activated under certain conditions (as has been
demonstrated [26,31]), such as cytokine stimulation, resulting
(in humans) in an isoform 27 amino acids larger than the normal
isoform.
This last point is relevant to two studies that focused on the
regulation of the canonical promoter [26,31]. A previous study
by some of us showed that CanE1-specific NOD2 transcripts
were up-regulated up to 20-fold by TNF-α and/or IFN-γ
treatment [26], which may then allow them to approach the
abundance of the AltE1-specific transcripts. The parallel study
by Gutierrez et al. also showed 70-fold up-regulation by TNF-α,
though in this case all NOD2 transcripts were assayed (by using
primers in exons 2 and 4) [31]. Both groups also showed that the
CanE1 promoter was responsive to these agents in a luciferase-
based reporter assay and that this responsiveness was dependent
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conducted before our discovery that AltE1 is the main
constitutive first exon in unstimulated tissues; our preliminary
findings reported here fail to detect changes in the relative usage
of AltE1 and CanE1 following stimulation with TNF-α, and
further work needs to be done to reconcile these apparent
discrepancies.
The identification of mammalian first exons is notoriously
difficult; they are often noncoding or contain little conserved
coding potential, they are poorly conserved between species
(with some spectacular exceptions), poorly represented in
cDNA libraries, and directly obtainable only by 5′RACE, an
arguably challenging technique when applied to low-abundance
transcripts. As there exists a finite, albeit low, number of
transcripts bearing CanE1, it is perhaps unsurprising that the
ability of various workers to amplify such transcripts by RT-
PCR has evidently masked the identity of the constitutive first
exon of the human NOD2 gene.
One of the immediate implications for the NOD2 field is the
simple fact that the constitutive human NOD2 protein has 27
fewer amino acids than previously thought. This presents
nomenclatural problems for the many known coding variants,
all of which have been named, as is conventional, according to
the number of the codon in the reference sequence that they
affect. The reference coding sequence starts at Met1 of a cDNA
sequence bearing CanE1. Our discovery means that this
numbering system is formally incorrect (the old Met28 is the
first codon of the principal NOD2 reading frame) and that there
is no conventional way of indicating variants in the true first
exon, AltE1. Given the large amount of data concerning NOD2/
CARD15 variants that have previously been published, how-
ever, we do not believe that renumbering of the human NOD2
reference sequence would be helpful. A further implication of
our work is that primate and nonprimate NOD2 proteins are
more similar than was previously thought, which should make
extrapolation of findings in model organisms simpler.
Perhaps the most pressing implication of the discovery of
AltE1 was that the promoter and one of the exons of this
important disease gene had never to our knowledge been tested
for CD-predisposing variants. We screened for variants in this
region and tested a range of length-variant haplotypes for
association with CD in a case–control study. No association was
observed, and we conclude that common variation in the
promoter and first exon region of the NOD2 gene does not
predispose to (or protect against) CD. Given the types of NOD2
variants that are known to be associated with CD, this is
perhaps unsurprising, and it might be expected that variants that
qualitatively or quantitatively alter the transcription of the
NOD2 gene, rather than the structure of its protein product,
would have distinct phenotypic consequences.
The well-known high incidence of colitis and bowel cancer
in captive S. oedipus appears to be unlikely to be causally
related to the initially intriguing frameshifting mutations in
NOD2 CanE1. However, our perusal of the literature empha-
sizes that while the high prevalence of bowel cancer may be
restricted to S. oedipus, a high incidence of chronic colitis,
described as “Crohn’s disease-like” [24], is widespread incaptive individuals of most callitrichid species. Clearly a NOD2
mutation in the last common ancestor of callitrichids remains a
candidate contributor to this colitis. Our previous study [6]
highlights 57 amino acid differences between the S. oedipus
NOD2 protein sequence and the human one; 23 of these
substitutions are not present in any other known vertebrate
NOD2 sequence. In addition, we have found that S. oedipus, S.
labiatus, and Ca. jacchus (and presumably, therefore, other
callitrichids) have a duplication of exons 5 and 6—the
relationship of these copies to the NOD2 gene is unknown,
though they do not appear to be incorporated into the NOD2
transcript (data not shown). All of these callitrichid-specific
variants are candidate factors in the etiology of captive
callitrichid colitis.
In summary, we believe that we have compiled a persuasive
case that the constitutive promoter of the human NOD2/
CARD15 gene in pathologically relevant tissues has previously
escaped identification. This brings the human gene more in line
with other mammalian NOD2 genes and will enable studies of
the transcriptional regulation of NOD2 to proceed on a surer
basis. In addition, we show that there is no evidence for the
involvement of promoter variants in the pathogenesis of CD.
Materials and methods
DNA and RNA preparation
Genomic DNA from callitrichids was previously extracted from blood or
tissue using Qiagen kits (see Mundy and Kelly [33] for details of sample
provenance). Fresh whole human or Ca. jacchus blood was diluted in 4 volumes
of red blood cell lysis buffer (0.1 mM EDTA, 155 mM NH4Cl, 10 mM KHCO3)
and incubated on ice for 15 min, followed by centrifugation at 400 g for 10 min.
The resulting mononuclear cell pellet was resuspended in 2 volumes of red
blood cell lysis buffer and further centrifuged at 400 g for 10 min at 4°C. For
TNF-α stimulation, the mononuclear cells were resuspended in RPMI medium
(Sigma, Poole, UK) supplemented with 10% fetal bovine serum, 2 mM
L-glutamine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin and were cultured
overnight at 37°C in 5% CO2. Aliquots of 1×10
6 cells (viability N95%) were
transferred to a final volume of 3 ml RPMI medium, with or without 10 μg/ml
TNF-α (R&D Systems, Abingdon, UK) and cultured for a further 24 h.
Mononuclear cells were harvested by centrifugation at 400 g for 10 min. RNA
was isolated from the primary and cultured mononuclear cell pellets using
RNeasy Spin columns (Qiagen, Crawley, UK) according to the manufacturer’s
protocol. Additionally, total RNA from ascending colon, duodenum, and adult
breast tissue was purchased from Stratagene (La Jolla, CA, USA); these tissues
are from three distinct single donors.
Genomic PCR, cloning, and sequence analysis
To amplify the CanE1 region from primate genomic DNA, the following
primers were used: CanE1F, 5′-TGGAAGGCTGGTTGGCCAACTCTG-3′,
and CanE1R, 5′-ATGTCGCGGCCAAGGATGAAAGAA-3′ (product size
314 bp). For amplification of AltE1 genomic region from H. sapiens, Ce.
aethiops, and S. oedipus, a range of primers based on the human sequence was
used, different pairs working on each species (primer sequences available on
request; product sizes ranging up to 497 bp). Amplification reactions were
performed in 10-μl reaction volumes with 20 ng DNA, 0.5 U Taq DNA
polymerase (Promega Corp., Southampton, UK), 1 μl 10×reaction buffer,
2.5 mM MgCl2, 0.2 mM dNTP, 2 μM each oligonucleotide primer. Reactions
were heat-denatured for 2 min at 90°C followed by 30 cycles of 90°C for 30 s,
60°C for 30 s, 72°C for 1 min. PCR products were sequenced directly as follows:
4 μl of PCR product was incubated with 1 μl ExoSAP-IT (USB, Staufen,
Germany) at 37°C for 15 min, followed by 80°C for 15 min, and sequenced
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UK) according to the manufacturer’s instructions. Products were analyzed using
an ABI 3730XL DNA analyzer.
Heterologous expression and Western blots
Expression constructs with differing first exon sequences were generated
by synthesizing long (109-nt) primers comprising ∼80 nt of human, primate,
or mutant CanE1 or AltE1 followed by 23 nt of exon 2 (see Supplementary
Fig. 1A). These were used for genomic PCR with a common reverse primer,
which incorporated sequence encoding an HA tag. Genomic DNAs from H.
sapiens, S. oedipus, and A. trivirgatus were used as templates. PCR products
were cloned into mammalian expression vector pGW1-CMV, verified by
sequence analysis, and transfected into cultured COS-7 cells using Polyfect
(Qiagen) reagent according to manufacturer’s recommendations. Cell lysates
were subjected to discontinuous tricine–PAGE using 10–20% gradient gels
(Bio-Rad), electroblotted onto Hybond-N nitrocellulose membrane (Amer-
sham), and probed with primary antibodies to the HA tag (Santa Cruz
Biotech) and to α-tubulin (Santa Cruz Biotech). Secondary antibody
conjugated to HRP was detected using an ECL detection kit (Amersham)
according to the manufacturer’s recommendations.
Semiquantitative RT-PCR
One microgram of RNA and 0.5 μg random hexanucleotide primers were
mixed and heated at 70°C for 5 min. Reverse transcription was then performed in
a 25-μl volume at 37°C for 1 h using 1 U RNase inhibitor (Promega), 200 U
MMLV reverse transcriptase (Promega), 0.5 mM dNTP, and Promega RT
reaction buffer. cDNA amplification was performed on 2.5 μl of the resulting
cDNA products, using 0.2 U Taq polymerase (Promega), Promega PCR buffer,
2 mM MgCl2, 0.2 mM dNTP, and 2 μM each primer in a final volume of 25 μl.
Reactions were denatured at 95°C for 2 min and then subjected to a variable
number of cycles of 92°C for 30 s, 65°C for 30 s, and 72°C for 1 min, followed by
72°C for 5 min. Products were analyzed at various cycle numbers to ensure that
the reactions were still in a logarithmic phase; those shown in Fig. 3 had been
subjected to 40 cycles. The following primers were used to amplify parts of the
NOD2 transcript: Ex4F, 5′-CTTGGTGTCTGCAAGGCTCT-3′, and Ex12R, 5′-
CAAAGCAAGAGTCTGGTGTCC-3′ (product size 686 bp); CanEx1F, 5′-
CTCTCMYGATGAGGAGGAAAG-3′, and Ex4R, 5′-CCAGACCTCCAGGA-
CATTCT-3′ (757 bp); Ex2F, 5′-ATTGTCAGGAGGCTCCACAG-3′, and Ex4R
(360 bp); AltEx1F, 5′-CGGAGYGGGCCTTGGAGTCG-3′, and Ex4R
(745 bp). Ambiguous nucleotides, given in IUPAC nomenclature, indicate
degeneracies incorporated to allow amplification of both human and marmoset
sequences. The control reaction used primers GAPDH_F, 5′-TCATCTCTGCC-
CCCTCTGCT-3′, and GAPDH_R, 5′-CGACGCCTGCTTCACCACCT-3′
(440 bp).
5′cRACE
5′cRACE was performed on human white blood cell RNA according to
Maruyama et al. [27], using Ex2RT (5′-phospho-TCCCATGCCAGGTCCAG-
CATG-3′) to prime the reverse transcription, Ex2OutF (5′-CCAGCCTCTCTC-
CCACTTGGC-3′) and Ex2OutR (5′-CCAGGACAGCAGCCAGTCCAG-3′)
to perform the first round PCR, and Ex2InF (5′-CAGAAGCTCATCGCG-
GCTGCC-3′) and Ex2InR (5′-CCTGAGACCAGCAGCTCGACC-3′) to per-
form the second round PCR. Products larger than 150 bp were gel-purified using
QiaQuick columns (Qiagen) and TA-cloned into pCR4-TOPO vector (Invitro-
gen), after which plasmid DNAwas prepared using a Qiaprep plasmid miniprep
kit (Qiagen).
Genotyping of polymorphic microsatellites
PCR amplification of the NOD2 promoter microsatellite repeat region
upstream of AltE1 was performed on 10 ng of genomic DNA using 0.3 U Super
Hot Taq DNA polymerase (Web Scientific, Crewe, UK), 0.5 μl 10×reaction
buffer, 1 mM MgCl2, 30 ng each oligonucleotide primer (CARDrepF, 5′-
TTTTCCTAGTTTTGGCTGTGTG-3′, and CARDrepR, 5′ACACAAA-CATGCTTCCCAATATA-3′), 0.1 mM each dNTP, and 160 nM fluorescently
labeled dUTP (Applied Biosystems) in a final volume of 5 μl. Reactions were
heat-denatured for 6 min at 95°C followed by 30 cycles of 95°C for 30 s, 65°C
for 30 s, and 72°C for 1 min.
For genotyping of the microsatellite repeats, 1 μl of PCR product was
resuspended in 9 μl HIDI formamide (Applied Biosystems) containing the
Genescan 500[ROX] size marker (Applied Biosystems) and resolved using the
ABI 3730XL DNA analyzer. Genotypes were automatically called using the
GeneMapper software and validated by comparison with a subset of alleles in
which the microsatellite repeat length had been previously determined by DNA
sequencing.
Clinical samples and statistical analysis
The ascertainment, diagnosis, and collection of samples from Crohn's
disease patients have been previously described [34]. Population controls were
obtained from the 1958 British Birth Cohort DNA collection (http://www.cls.
ioe.ac.uk). The distribution of the upstream length variant haplotypes was
compared between cases and controls using a χ2 test. Observed data for rare
haplotypes 10–3–4 and 8–5–5 were pooled to avoid violation of the
assumptions of the χ2 distribution. The frequencies of common haplotypes
were also compared using binomial tests for difference in proportions.
Bioinformatics
Public domain genomic sequences were obtained from the Ensembl Genome
Server (http://www.ensembl.org/index.html) and NCBI (http://www.ncbi.nlm.
nih.gov), curated in VectorNTI (InforMax, Inc.), and manipulated in BioEdit
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Novel sequence data were
analyzed using ContigExpress (InforMax, Inc.). Alignments were done using
ClustalW and most phylogenetic analysis was performed using programs from
the Phylip package [35], all within the BioEdit platform. CpG island analysis
was done by CpG Island Detector at http://cpgislands.usc.edu/ [36]. Ka/Ks ratios
were calculated using the FUGE bioinformatics platform (http://www.bioinfo.
no/tools/kaks) [37].Acknowledgments
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